IVAN JAVIER
NUÑEZ GIL
PROFESOR
Hospital Universitario de Getafe
Getafe, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Getafe (31)
2023
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry
Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78
-
Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry
Revista Portuguesa de Cardiologia, Vol. 42, Núm. 3, pp. 237-246
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries
Frontiers in Cardiovascular Medicine, Vol. 9
-
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278
-
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 9, pp. 2520-2528
2021
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615
-
COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)
European Journal of Clinical Investigation, Vol. 51, Núm. 11
-
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Infection, Vol. 49, Núm. 4, pp. 677-684
-
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart
Clinical and Experimental Medicine, Vol. 21, Núm. 2, pp. 249-268
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Age and ageing, Vol. 50, Núm. 2, pp. 326-334
-
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry
Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280
-
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19
Journal of hospital medicine, Vol. 16, Núm. 6, pp. 349-352
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966